Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Low testosterone may indicate severe COVID-19 in men.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.